NCT07316686: Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

Sponsor: Instituto do Cancer do Estado de São Paulo. Phase: PHASE1. Conditions: Prostate Cancer (Adenocarcinoma)